Position in EOLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,985,216
-$6,298,635 QoQ
Shares Held
483,021
-61.2% QoQ
Ownership
0.733%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TANG CAPITAL MANAGEMENT LLC holds $172,756,521 across 4 Drug Manufacturers - Specialty & Generic names. EOLS ranks #4 (1.1% of the industry book) .
All Filings in EOLS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,985,216 | 483,021 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $8,283,851 | 1,245,692 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $33,698,155 | 5,488,299 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $46,026,044 | 4,997,399 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $60,118,709 | 4,997,399 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $55,171,284 | 4,997,399 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $78,527,863 | 4,847,399 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $52,594,279 | 4,847,399 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $58,063,586 | 4,147,399 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $32,615,611 | 3,097,399 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $28,310,226 | 3,097,399 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $22,518,090 | 3,097,399 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $27,049,995 | 3,197,399 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $6,079,254 | 809,488 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $293,937 | 36,514 | Shares | Other | 2022-11-14 | |
| 2020-03-31 | $13,674,250 | 3,295,000 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||